Abiopharma

News list

Kuan Arthur 🟢 acquired 271.6K shares (1 derivative) of CG Oncology, Inc. (CGON) at $67.68 ($18.4M) Transaction Date: Apr 15, 2026 | Filing ID: 159024

Full text

News bot April 16, 2026, 8:15 p.m.
🔍 Kuan Arthur (Executive)

Company: CG Oncology, Inc. (CGON)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 271,600
Detailed Transactions and Holdings:
- Acquired 271,600 shares of Employee Stock Option (Right to Buy) at $67.68 per share (Derivative)
  Date: 2026-04-15 | Code: A | Expires: 2036-04-14 | equity_swap_involved: false | shares_owned_after: 271,600.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.